Litigation Details for Keryx Biopharmaceuticals, Inc. v. Lupin Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Keryx Biopharmaceuticals, Inc. v. Lupin Ltd. (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-05-10 |
| Court | District Court, D. Delaware | Date Terminated | 2020-10-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Defendant | Referred To | |
| Patents | 7,767,851; 8,093,423; 8,299,298; 8,338,642; 8,609,896; 8,754,257; 8,754,258; 8,846,976; 8,901,349; 9,050,316; 9,328,133; 9,387,191; 9,757,416 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Keryx Biopharmaceuticals, Inc. v. Lupin Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Keryx Biopharmaceuticals, Inc. v. Lupin Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-05-10 | 1 | Complaint | United States Patent Nos. 5,753,706 (the “’706 patent”); 7,767,851 (the “’851 patent”); 8,093,423 (the…(the “’423 patent”); 8,299,298 (the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896…’896 patent”); 8,754,257 (the “’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent…,349 (the “’349 patent”); 9,050,316 (the “’316 patent”); 9,387,191 (the “’191 patent”); and 9,757,416… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C | External link to document |
| 2019-06-04 | 10 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,328,133 . (Phillips, John) …2019 5 October 2020 1:19-cv-00884 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
